TOP STORIES

• TRENDS IFN-Free Drugs Upending Hepatitis C Market Landscape
  July 17, 2015

• BUSINESS ASCO Immunotherapy Roundup - 3: AZ Set to Harness Rich Pipeline to Pursue Combo Strategy
  July 16, 2015

• BUSINESS As 80% Era Looms, 3 Generic Majors Will Emerge as Dominant Suppliers: Sawai
  July 16, 2015

• ORGANIZATION Drug Pricing Tomorrow: Kenporen Veep Wants Holistic Drug Policy in FY2016 Reform
  July 15, 2015

• REGULATORY Drug Pricing Tomorrow: Full Interview with MHLW Economic Affairs Head Jo - Part 2
  July 15, 2015

• BUSINESS ASCO Immunotherapy Roundup - 2: Chugai Has High Hopes for Atezolizumab Combos with Group Portfolios
  July 14, 2015

• REGULATORY Govt, Pharma Leaders to Meet in August for Drafting of “Comprehensive Strategy”
  July 13, 2015

• ORGANIZATION “Humanitarian Trials” Hefty Burden on Drug Makers: JPMA Regulatory Head
  July 10, 2015

• REGULATORY MHLW to Seek “Candidate Drug Lists” for Patient-Initiated Mixed Care from Medical Societies
  July 9, 2015

• BUSINESS Sawai Gearing Up to Revise 3-Year Biz Plan after New Generic Target
  July 8, 2015

• REGULATORY Drug Pricing Tomorrow: Full Interview with MHLW Economic Affairs Head Jo - Part 1
  July 8, 2015

• BUSINESS ASCO Immunotherapy Roundup - 1: Opdivo Data Boost Confidence in BMS’s Combination Strategy
  July 7, 2015

• BUSINESS Foreign Drug Makers’ Sales Dip on Generic Inroads in 2014
  July 6, 2015

• REGULATORY NCC Eyes Trial Enrollment of 150 Rare Cancer Patients under Registry Initiative
  July 3, 2015

• ORGANIZATION FPMAJ Chair Hails Innovation-Fueling Policies in Govt Fiscal Plan
  July 2, 2015

• REGULATORY Drug Pricing Tomorrow: Full Interview with Ex-Chuikyo Chairman Endo
  July 2, 2015

• REGULATORY Japan Cabinet OKs Fiscal Policy Guidelines, Marking Dawn of “80% Generic” Era
  July 1, 2015

• TRENDS 3 Major Japan Makers Shed 1,300 Jobs amid Redundancy Programs
  June 30, 2015

• REGULATORY Drug Pricing Tomorrow: MHLW’s Jo Says Price-Maintenance Premium Crucial as Post-Launch Reward for Innovation
  June 29, 2015

• TRENDS “80% Generic” Era Would Further Accelerate Contraction of Market for Long-Listed Drugs
  June 29, 2015

ページ

• « 先頭
• ‹ Prev
• …
• 185
• 186
• 187
• 188
• 189
• 190
• 191
• 192
• 193
• …
• Next ›
• 最終 »